Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Bone Marrow Transplant. 2007 Dec 17;41(7):635–642. doi: 10.1038/sj.bmt.1705952

Table 2.

Univariate probabilities of outcomes by donor type and disease status.

Unrelated Donor
Autologous
All patients
(n = 159)
CR1
(n = 76)
CR2
(n = 83)
All patients
(n = 101)
CR1
(n = 64)
CR2
(n = 37)
TRM
 @ 100 days 28% 23% 32% 5% 5% 6%
 @ 1 year 43% 45% 41% 8% 9% 6%
 @ 2 years 45% 47% 43% 9% 12%
Relapse
 @ 1 year 13% 5% 21% 49% 38% 69%
 @ 2 years 18% 12% 23% 54% 41% 75%
 @ 3 years 20% 15% 25% 58% 45% 81%
 @ 5 years 21% 15% 26% 58% 45% 81%
Leukemia-Free Survival
 @ 1 year 43% 49% 38% 42% 52% 24%
 @ 2 years 37% 41% 33% 37% 47% 19%
 @ 3 years 35% 39% 31% 31% 42% 14%
 @ 5 years 33% 37% 29% 29% 39% 14%
Overall Survival
 @ 1 year 47% 51% 42% 52% 59% 41%
 @ 2 years 40% 45% 36% 41% 51% 24%
 @ 3 years 37% 42% 33% 37% 48% 19%
 @ 5 years 34% 38% 30% 29% 39% 14%

Legend: CR1 = first complete remission; CR2 = second complete remission; TRM = Treatment-related mortality.